These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 379690)

  • 1. Tremor due to sodium valproate.
    Hyman NM; Dennis PD; Sinclair KG
    Neurology; 1979 Aug; 29(8):1177-80. PubMed ID: 379690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate tremors.
    Karas BJ; Wilder BJ; Hammond EJ; Bauman AW
    Neurology; 1982 Apr; 32(4):428-32. PubMed ID: 6801541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and surface EMG characteristics of valproate induced tremors.
    Mehndiratta MM; Satyawani M; Gupta S; Khwaja GA
    Electromyogr Clin Neurophysiol; 2005; 45(3):177-82. PubMed ID: 15981690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing features between valproate-induced tremor and essential tremor.
    Alonso-Juarez M; Baizabal-Carvallo JF
    Acta Neurol Scand; 2018 Aug; 138(2):177-181. PubMed ID: 29749618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor.
    Paparella G; Angelini L; De Biase A; Cannavacciuolo A; Colella D; Di Bonaventura C; Giallonardo AT; Berardelli A; Bologna M
    Cerebellum; 2021 Jun; 20(3):374-383. PubMed ID: 33200286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate.
    Rinnerthaler M; Luef G; Mueller J; Seppi K; Wissel J; Trinka E; Bauer G; Poewe W
    Epilepsia; 2005 Feb; 46(2):320-3. PubMed ID: 15679514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate induced tremor in a patient with epilepsy and Down's syndrome.
    Siniscalchi A; Gallelli L; Loizzo S; Tiziana A; Russo E; De Sarro G
    Curr Drug Saf; 2013 Feb; 8(1):69-71. PubMed ID: 23656451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical features and functional impact of valproate-induced tremor.
    Alonso-Juarez M; Torres-Russotto D; Crespo-Morfin P; Baizabal-Carvallo JF
    Parkinsonism Relat Disord; 2017 Nov; 44():147-150. PubMed ID: 28941829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tremor due to sodium valproate.
    Mattson RH; Cramer JA
    Neurology; 1981 Jan; 31(1):114. PubMed ID: 6779221
    [No Abstract]   [Full Text] [Related]  

  • 10. Valproate-induced rest tremor and parkinsonism.
    Baizabal-Carvallo JF; Alonso-Juarez M
    Acta Neurol Belg; 2021 Apr; 121(2):515-519. PubMed ID: 31721077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tremor in the course of sodium valproate treatment].
    Dugas M; Brunod R; Masson M
    Nouv Presse Med; 1981 Sep; 10(34):2828. PubMed ID: 6796937
    [No Abstract]   [Full Text] [Related]  

  • 12. Disabling Resting Tremors Induced by the Short-term Infusion of Valproate: A Reversible Phenomenon.
    Gupta A; Kushwaha S
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():615. PubMed ID: 30619645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetazolamide appears effective in the management of valproate-induced tremor.
    Lancman ME; Asconapé JJ; Walker F
    Mov Disord; 1994 May; 9(3):369. PubMed ID: 8041383
    [No Abstract]   [Full Text] [Related]  

  • 14. Quantitative analysis of motor performance in epilepsy patients treated with valproate.
    Farkas Z; Gulyás S; Molnár R; Szirmai I; Kamondi A
    Seizure; 2010 Apr; 19(3):173-7. PubMed ID: 20167509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of sodium valproate.
    Cowan A
    Neurology; 1980 Mar; 30(3):336. PubMed ID: 6767202
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up.
    McCabe PH; Michel NC; McNew CD; Lehman EB
    Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monotherapy with sodium valproate in generalized primary epilepsy. 2d phase: Study of long-term efficacy and tolerance].
    Feuerstein J; Revol M; Roger J; Sallou C; Truelle JL; Vercelletto P; Weber M
    Sem Hop; 1983 Apr; 59(16):1263-74. PubMed ID: 6191393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate].
    van der Zwan A
    Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical characteristics and related factors of tremor in patients with epilepsy.
    Xiao Y; Xiong W; Lu L; Chen J; Zhang Y; Jiang X; Zhou D
    Seizure; 2019 Mar; 66():70-75. PubMed ID: 30807902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of Serum Valproate Concentration Monitoring in Patients with Bipolar Disorder Type I at Srinagarind Hospital Outpatient Clinic.
    Paholpak P; Paholpak S; Patanasethanant D; Rangseekajee P; Patjanasoontorn N
    J Med Assoc Thai; 2016 Oct; 99(10):1153-60. PubMed ID: 29952475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.